Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements

Completed

Conditions studied: Pre-Eclampsia

In brief

The purpose of this study is to compare the feasibility and accuracy of two methods of non-invasive hemodynamic assessments - bioreactance as assessed by non-invasive cardiac output monitoring (NICOM; Cheetah Medical) and pulse wave analysis as assessed by finger cuff arterial pressure (ClearSite, Edwards Life Sciences) - compared to hemodynamic assessments by intermittent echocardiography in early onset preeclampsia.

Key facts

Study ID

NCT05299229

Run by

Yale University

People needed

12

Starts

2020-12-29

Expected to finish

2021-12-31

Last updated by the study team

2022-08-12

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• BP >160 or DBP >110
• gestational age between 20-34 weeks
• singleton pregnancy

You may not qualify if…

• prior diagnosis of chronic hypertension or hypertensive disorder of pregnancy
• multi-fetal pregnancy

Where it is running

• Yale University Hospital — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.